NEVVI Medicare utilization intelligence

Compare this medication with others →

Medicare Part D market

Ammonium Lactate

CY2024
Medicare Part D · CY2024 · as published by CMS
Part D Ammonium Lactate Medication
ScopeMedicare Part D prescription drug plans, Medicare Advantage drug plans included, CY2024. A claim is one dispensed fill, refills included. It is not a prescription written and not a patient count.
Sold as
share of claimsprescribers, this brand row
Ammonium Lactate 100.0% 95,677
In CMS's filePublished in every year, CY2020–CY2024, as Ammonium Lactate.
Part D drug cost included in Explore Explore — see the Part D drug cost for this → Gross amount paid at the pharmacy, before manufacturer rebates.
As published by CMS · Medicare Part D Prescribers by Geography and Drug, and by Provider and Drug, CY2024
Market overview
  • Market size 1,270,129 claims for Ammonium Lactate in CY2024, and 1,497,481 30-day fills, as CMS publishes them.
  • Growth Up 12.0% year over year; +28.3% over five years (2020 → 2024).
  • Prescribers CMS reports 95,677 prescribers of Ammonium Lactate nationally in CY2024.
  • Where it is prescribed The three largest state markets are New York, Florida, and New Jersey — together 53.8% of claims.
How to read these figures

Claims count dispensed fills, refills included; a claim is not a prescription written and not a patient count. CMS withholds any prescriber with 10 or fewer claims for a brand row, so a prescriber missing from a list is not confirmed absent and every disclosed count is a floor. Totals and prescriber rows come from two separate CMS files that are not built to reconcile, so a prescriber list never adds up to a published total. Shares are computed only against the totals CMS publishes for the place. Prescriber counts belong to one brand row and are never summed across brands, because one clinician can write several brands. All figures are calendar years.

This medication's Overview — its five-year claims trend, and how many state markets publish a total for it — is part of Explore.

See the Part D drug cost

An Explore subscription, $249 a seat a year, opens this medication's Overview, and shows what Medicare Part D spends on it.

It comes with 25 credits a seat a year for Deep Dives, which open the rest.

Subscribe to Explore →

Included in Explore. Part of a Deep Dive.